Annual report pursuant to Section 13 and 15(d)

Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income by Reportable Segment (Details)

v3.19.1
Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income by Reportable Segment (Details) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Net revenue $ 50,545,781 $ 31,810,635
Direct operating costs 31,252,535 17,679,070
Selling and marketing 1,611,982 1,106,698
General and administrative 16,264,473 11,738,201
Research and development 1,029,510 1,081,832
Change in contingent consideration 73,271 151,423
Depreciation and amortization 2,853,827 4,299,943
Total operating expenses 53,085,598 36,332,795
Operating income (loss) (2,539,817) $ (4,522,160)
Healthcare IT [Member]    
Net revenue 44,044,700  
Direct operating costs 26,289,770  
Selling and marketing 1,593,052  
General and administrative 9,834,749  
Research and development 1,029,510  
Change in contingent consideration 73,271  
Depreciation and amortization 2,700,577  
Total operating expenses 41,520,929  
Operating income (loss) 2,523,771  
Practice Management Segment [Member]    
Net revenue 6,501,081  
Direct operating costs 4,962,765  
Selling and marketing 18,930  
General and administrative 1,164,505  
Research and development  
Change in contingent consideration  
Depreciation and amortization 153,250  
Total operating expenses 6,299,450  
Operating income (loss) 201,631  
Unallocated Corporate Expenses [Member]    
Net revenue  
Direct operating costs  
Selling and marketing  
General and administrative 5,265,219  
Research and development  
Change in contingent consideration  
Depreciation and amortization  
Total operating expenses 5,265,219  
Operating income (loss) $ (5,265,219)